• Printer Friendly
  • Text Resizer - Small
  • Text Resizer - Large
  • Email this page
Event enquiries
Event Coordinator
Strategy & Communications
Call: 02 8217 8700
Email an enquiry

  Contact us

National Medicines Symposium National Medicines Symposium

When: From: 14th May 2008 to 16th May 2008
Where: Canberra
Audience: Consumers; Health Professionals; Members and Stakeholders
Host: NPS

Description:

QUM: what does it really mean for you? The science, the policy and the practice.

Recordings available

The 2008 National Medicines Symposium is over.

NPS offers audio recordings and presentation notes from its highlight presentations for free. Contact our Events Coordinator to order a copy.

You can download the event program here.

Welcome message

"National Prescribing Service Limited (NPS) and the Pharmaceutical Health And Rational use of Medicines (PHARM) Committee take great pleasure in inviting you to attend the National Medicines Symposium (NMS) 2008. The theme for the fifth biennial conference is QUM: what does it really mean for you? The science, the policy and the practice.

We will address the synergies and disparities between science, policy and practice in delivering Quality Use of Medicines (QUM) across the health sector. We are seeking a variety of perspectives and views from health professionals, consumers, the pharmaceutical industry, academics, indigenous and multicultural communities. Our focus will be on how science, policy and practice are inextricably linked and how the integration of these elements can positively affect QUM. Conversely we will also examine the negative impacts that result when these areas are not working in harmony.

This will be an excellent opportunity to discuss medicine concerns for specific communities, opportunities for integration and information sharing across the health sector and issues surrounding access to data.

NMS 2008 is a platform to share expertise and experience, to showcase international and national best practice in QUM. This stimulating scientific program brings together health professionals, consumers, policy makers, project and program coordinators, researchers and academics, the pharmaceutical industry, government departments, health organisations, medical writers and other experts. This represents a rare opportunity to obtain a global perspective of the current and future state of QUM.

We encourage you to contribute to the Symposium with your own knowledge and experience and look forward to welcoming you at NMS 2008."

Dr Janette Randall Chair, NPS
Prof Ric Day Chair, PHARM

Important dates

Abstract submission closes:
Friday 8 February 2008

Abstract notification to authors:
Friday 14 March 2008

Early registration deadline:
Monday 7 April 2008

Accommodation booking deadline:
Monday 7 April 2008

National Medicines Symposium:
Wednesday 14 - Friday 16 May 2008

Symposium streams

The Science

This stream explores the research and evidence that support QUM activities. The methodological issues for measuring QUM impacts, use of linked data sets and research that builds the QUM knowledge base will be highlights.

The Policy

The development and implementation of policy is a powerful force influencing QUM principles across the health sector and the consequence of ineffective policy can be far-reaching. This stream explores how we influence positive policy development and presentations will focus on the political economy and QUM, the implications for QUM in an ageing world, measuring the impacts of policy and the gaps between practice, policy and research.

The Practice

Medicines use for a diverse community occurs within a complex health environment and an informed community taking an active role in their healthcare is likely to benefit QUM.

A global perspective on the commitment to rational drug use will provide a broad framework to view QUM practice. Presentations in this stream will revolve around activating communities, QUM in a changing environment and QUM delivery through a diverse workforce. Safety and quality indicators in hospital settings and the role of the Home Medicines Review will be explored for their impact on the QUM agenda.

The science, policy and practice streams are inextricably linked and a closing session will illustrate that a seamless interaction between and across each area is required to ensure the positive evolution of QUM.

Who should attend?

  • Doctors and pharmacists
  • Nurse practitioners, clinical nurse specialists and practice nurses
  • Complementary medicines practitioners
  • Other health professionals
  • People running local QUM programs
  • Divisions of General Practice
  • Consumers, community and disease based organisations
  • Policy makers and regulators
  • Researchers and academics
  • Medicines industry
  • Government departments and government advisory bodies
  • Health organisations
  • Independent information providers
  • Medical writers

Guest speakers

Rachel Elliott

Lord Trent Professor of Medicines and Health
School of Pharmacy, Faculty of Science
University of Nottingham

Rachel Elliott
Rachel is a pharmacist with doctorate health economics training. She trained as an industrial pharmacist, was one of the first critical care specialist pharmacists in the UK, and gained a Department of Health funded PhD in health economics with Prof Martin Buxton (Health Economics Research Group, Brunel University). She worked as a clinical lecturer and then senior clinical lecturer at the School of Pharmacy and Pharmaceutical Sciences, University of Manchester, from 1996 to 2007. In 2004-2005, she won a Commonwealth Fund Harkness Fellowship "What is the relative importance of factors that influence patients' decisions to adhere to medicines and are they taken account of in health policy?" and spent a year at Harvard Medical School working with Prof Stephen Soumerai.

Rachel has applied her skills to many therapeutic areas and collaborations with other research groups, universities and NHS trusts in anaesthesia and surgery, infections, emergency hormonal contraception (EHC), acute and chronic analgesia, cystic fibrosis, juvenile idiopathic arthritis, cell salvage, drug-related morbidity, pharmacogenetics and adherence. She has published both primary and secondary economic evaluations in high quality journals. These have been based on randomised controlled trials, derived from controlled cohort data, or from indirect comparison meta-analysis or single-trial economic modeling. Rachel uses a wide range of methods: clinical trials, complex intervention (MRC framework) cluster trials, observational data collection, systematic review and meta-analysis, quantitative handling of cost, cost effectiveness and net benefit data (principally nonparametric bootstrapping, regression and simulation techniques, probabilistic and Bayesian economic analysis techniques), qualitative research, documentary analysis and discrete choice stated preference methods.

In May 2007, Rachel was appointed to her current position at the University of Nottingham. Rachel is also a member of a NICE (National Institute for Health and Clinical Excellence) appraisal committee.

Anita Hardon

Professor Anthropology of Care and Health
Amsterdam School for Social Science Research
University of Amsterdam

Anita Hardon
After completing her PhD on self-medication practices in the Philippines (1990), Anita Hardon was appointed as a lecturer in the Anthropology Department of the University of Amsterdam. Under her leadership and that of Professor Sjaak van der Geest, the University of Amsterdam developed an elaborate program in the field of pharmaceutical anthropology. Field studies were conducted in Africa and Asia, contributing to a rich body of knowledge on medicine use perceptions and practices. In 2000 Anita Hardon was appointed Professor in Anthropology of Care and Health. Between 2000 and 2005 she was chairperson of Health Action International, and director of the Amsterdam School for Social Science Research.

The empirical studies conducted under the leadership of Anita Hardon, generally involve collaborative and multidisciplinary fieldwork at global and national levels of health care and in local resource poor settings in Asia and Africa (funded by the European Union, bilateral donors, the Dutch Science Foundation, and NIH). Anita Hardon has conducted several evaluations of multilateral health and medicines programs, including WHO's Action program on Essential Drugs, and UNAIDS. She is an advisor to many health development agencies. Together with colleagues at the World Health Organization and Royal Tropical Institute she developed the international training course Promoting Rational Drug Use in the Community, which will be held for the 6th time in Capetown in July 2008.

Anita Hardon has published several books on medicines and society, including the Social Lives of Medicines (with Susan Reynolds Whyte and Sjaak van der Geest, 2002 published by Cambridge University Press), Medicines out of Control (with Charles Medawar, 2004 awarded the Prix du Livre in 2005 by Prescrire), and the manual How to Investigate Drug Use by Consumers (with Daphne Fresle and Catherine Hodgkin, 2004). She publishes regularly on medicine use issues in journals such as Social Science and Medicines, Health Policy and Planning, and Aids Care.

Jean R. Slutsky

Director, Center for Outcomes and Evidence
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services

Jean R. Slutsky
Ms. Slutsky has directed the Center for Outcomes and Evidence (COE), Agency for Healthcare Research and Quality (AHRQ) of the U.S. Department of Health and Human Services since June 2003. Prior to Ms. Slutsky's appointment as director of COE, she served as acting director of the Center for Practice and Technology Assessment at AHRQ. Most recently, Ms. Slutsky has implemented a comparative effectiveness research program that includes evidence synthesis, evidence generation, and evidence communication. The Effective Health Care Program is authorized under Section 1013 of the Medicare Modernization Act. Ms. Slutsky oversees the Evidence-based Practice Center program; Technology Assessment Program; extramural and intramural research portfolios concerning translating research into practice, outcomes and effectiveness research, including pharmaceutical outcomes, and cost-effectiveness analyses; and the National Guideline, Quality Measures, and QualityTools Clearinghouses. She is a vice chair of the Guidelines International Network and a member of the editorial board of Implementation Science.

Prior to becoming acting director of the Center for Practice and Technology Assessment, Ms. Slutsky, served as project director of the U.S. Preventive Services Task Force, an internationally recognized panel of experts who make evidence-based recommendations on clinical preventive services.

Ms. Slutsky received her Bachelor of Science degree at the University of Iowa, a Masters of Science in Public Health (Health Policy and Administration) from the University of North Carolina at Chapel Hill, and trained as a Physician Assistant at the University of Southern California.

Call for abstracts

Abstract submission has now closed. Authors will be notified of their abstract acceptance by Friday 14 March 2008. Successful presenting authors are required to register for the Symposium in order to ensure their abstract is included in the final program. The deadline for presenting author registration is Monday 7 April 2008.

QUM Asia-Pacific Scholarship

The National Prescribing Service Limited (NPS) is offering academics, policy makers and professionals, working to promote Quality Use of Medicines (QUM) in the Asia-Pacific region, a scholarship to attend the National Medicines Symposium (NMS) in Canberra, Australia. The scholarship aims to develop leadership, build capacity and grow partnerships within the Asia-Pacific on QUM.

For the recipient, the scholarship represents an international professional development opportunity and chance to develop links within Australia.

Scholarship applications have now closed. Applicants will be notified soon on the outcome of their submissions

Professional development

General Practitioners

  • Royal Australian College of General Practitioners (RACGP) Continuing Professional Development and Quality Assurance (QA&CPD) Program Category 2 points (2 per hour – maximum of 28) Activity 738252
  • Australian College of Rural and Remote Medicine (ACRRM) for professional development program points. 2 points (2 per hour – maximum of 28) Activity EEACR-8010-NPS-NMS.

Pharmacists

  • Pharmaceutical Society of Australia (PSA) members can self-record details or submit a completed evaluation form for Continuing Professional Development and Practice Improvement (CPD & PI) points, recognition number CR08-0009 1 point per hour with maximum of 14.
  • Society of Hospital Pharmacists of Australia (SHPA) members can self-record details of this activity on your SHPA CPD record sheet (download from the SHPA website www.shpa.org.au) — group 1 activity for maximum of 14 points
  • Australian Association of Consultant Pharmacy (AACP) members can self-record details of this activity on your AACP CPD record sheet (download from the AACP website www.aacp.org.au) — group 1 activity for maximum of 14 points.

Nurses

Royal College of Nursing Australia (RCNA) members can self-record details of this activity on your record sheet — APEC number 061110344 for maximum of 14 Continuing Nurse Education (CNE) points.

Evaluation forms

The Evaluation forms must be completed and returned to NPS for RACGP, ACRRM and/or points to be allocated.

Please retain your registration receipt in lieu of certificate of attendance.

Social program

Welcome reception and NPS 10th birthday celebration

All delegates are invited to attend the Welcome reception and to help us celebrate NPS' 10th birthday! Drinks and finger food will be served.

Venue:  National Convention Centre
Date:  Wednesday 14 May 2008
Time:  18:30 – 20:00
Cost:  Included in the registration fee for full delegates and students/unwaged. Tickets will not be automatically allocated. You will need to indicate on the registration form if you will be attending.

Additional tickets:  $50 per person

Symposium dinner and National QUM Awards

The National QUM Awards 2008 will be presented at the Symposium dinner. The awards will again be presented in six categories, enabling the work of all those who further QUM to be recognised. This may include health professionals, community members, students, consumers, pharmaceutical companies, government, health organisations and the media. For updates on the awards categories and ways to enter a nomination please visit www.nps.org.au/events

Venue:  National Convention Centre
Date:  Thursday 15 May 2008
Time:  19:00 – 22:30
Cost:  Included in the registration fee for full delegates. Tickets will not be automatically allocated. You will need to indicate on the registration form if you will be attending.

Additional tickets:  $95 per person

Privacy notice

In registering for NMS 2008 you consent to relevant details being incorporated into a participant list for the benefit of all delegates (name and organisation only). Details may be available to parties directly related to the Symposium including the Symposium Secretariat, NPS (including its board of directors and staff), PHARM Committee, the venue and accommodation providers (for the purpose of room bookings and Symposium options), and to inform you of future related symposia.

Where applicable, the information will also be provided to RACGP, ACRRM, PSA and the RCNA for the purpose of professional development point allocation relating to attendance.

Please indicate on the registration form if you do not wish to have your name included in the participants list.

Program

Download final program here.

Registration information

Online registration for NMS has now closed. If you wish to register for this event please contact Expert Events on (07) 3848 2100 or via email nms2008@expertevents.com.au.

About PHARM

PHARMLogo

Pharmaceutical Health And Rational use of Medicines (PHARM) is an expert advisory committee which oversees the Quality Use of Medicines (QUM) component of Australia's National Medicine Policy and provides expert advice to the Minister for Health and Ageing and the Department of Health and Ageing on the Quality Use of Medicines (QUM) strategy. The QUM strategy is based on a partnership approach between consumers, health professionals, industry and government. The PHARM Committee promotes and reviews the QUM strategy in Australia and oversees its implementation. Membership of the PHARM Committee is by appointment by the Minister for Health and Ageing.

NMS 2008 Scientific Program Committee

Dr Stephen Phillips, General Practitioner, Queensland, (Chair)

Professor Marc Cohen, President, Australian Integrative Medicines Association

Associate Professor Gabrielle Cooper, University of Canberra

Professor Ric Day, Pharmaceutical Health And Rational use of Medicines (PHARM) Committee Chair

Ms Rhonda Galbally AO, Chief Executive Officer, Our Community

Dr Paul Kubler, Dept Clinical Pharmacology, Royal Brisbane Hospital

Dr Rebekah Moles, Associate Lecturer, Faculty of Pharmacy, University of Sydney

Dr Greg Pearce, Medical Advisor, Alphapharm Pty Ltd & Pharmaceutical Health And Rational use of Medicines (PHARM) Committee member

Dr Marie Pirotta, Senior Lecturer, University of Melbourne

Dr Shiong Tan, Director, National Prescribing Service Limited

Dr Janney Wale, Consumer Representative, Consumers' Health Forum of Australia

Dr Lynn Weekes, Chief Executive Officer, National Prescribing Service Limited

Date published: 2011-01-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.